AEM vs CF

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

CF Industries presents a dichotomy between strong fundamental profitability and bearish sentiment indicators. The Piotroski F-Score of 4/9 indicates stable but non-optimal financial health, while the stock trades significantly above its Graham Number ($79.74) but well below its growth-based Intrinsic Value ($264.62). While the company boasts an impressive ROE of 23.40% and a very healthy current ratio of 3.37, these strengths are offset by aggressive insider selling and a high PEG ratio of 5.67, suggesting that current growth may be overpriced.